Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1994-05-19
1998-03-24
Cunningham, Thomas M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241431, 4241441, 4241841, 4241981, 514 2, 514 8, 530300, 53038822, 53038875, 530395, A61K 3800, A61K 39395, C07K 14705, C07K 1628
Patent
active
057309833
ABSTRACT:
The present invention relates to the use of intercellular adhesion molecule-1 (ICAM-1) or fragments thereof, anti-CD18 antibodies or fragments thereof, and members of the CD18 family of proteins or fragments thereof in the treatment of asthma.
REFERENCES:
Associated Press (Sep. 19, 1995), "Tests for nasal spray to deflect cold viruses".
Gundel Robert H.
Rothlein Robert
Wegner Craig D.
Boehringer Ingelheim Pharmaceuticals Inc.
Cunningham Thomas M.
LandOfFree
Use of intercellular adhesion molecules, and their binding ligan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of intercellular adhesion molecules, and their binding ligan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of intercellular adhesion molecules, and their binding ligan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2286733